CA Patent

CA2616177C — Imidazolylalkyl-pyridines for the treatment of a sleep disorder

Assigned to Individual · Expires 2012-05-01 · 14y expired

What this patent protects

The present invention relates to the use of certain imidazolylalkyl-pyridines as wakefulness compounds.

USPTO Abstract

The present invention relates to the use of certain imidazolylalkyl-pyridines as wakefulness compounds.

Drugs covered by this patent

Patent Metadata

Patent number: CA2616177C
Jurisdiction: CA
Classification: —
Expires: 2012-05-01
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.